Research, Policy

April 2023 PDUFA Calendar

Ira Loss, EVP Health Care Analyst
27 March 2023


Delays in approvals due to disrupted work schedules at FDA because of the coronavirus are likely to be fewer in the coming months. The biggest current issue preventing approvals looks to be completion of foreign inspections of manufacturing facilities, particularly in Asia. A significant number of complete response letters and extended user fee dates have been issued by the agency due to the inability to complete the inspections.

Want to learn more? Download the Report.


Public Policy Research
Identify opportunity and risks driven by public policy.
Fundamental Equity Research
Gain a comprehensive view of global themes, industries, and companies.
Forensic Accounting Research
Understand implications of public company financial reporting.